Association of a peptoid ligand with the apical loop of pri-miR-21 inhibits cleavage by Drosha

RNA

Volumn 20, Issue 4, 2014, Pages 528-539

  Diaz, Jason P ^a   Chirayil, Rachel ^a   Chirayil, Sara ^a   Tom, Martin ^a   Head, Katie J ^a   Luebke, Kevin J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Drosha; MiR 21; MiRNA processing; Peptoid; RNA hairpin loop

Indexed keywords

GLYCINE DERIVATIVE; LIGAND; MICRORNA 16; MICRORNA 21; PEPTOID; PROTEIN DGCR8; PROTEIN DROSHA; RIBONUCLEASE; RNA PRECURSOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; COMBINATORIAL LIBRARY; DRUG SCREENING; HUMAN; HUMAN CELL; LIGAND BINDING; MICROARRAY ANALYSIS; PRIORITY JOURNAL; RNA CLEAVAGE; RNA PROCESSING;

DROSHA; MIR-21; MIRNA PROCESSING; PEPTOID; RNA HAIRPIN LOOP;

HUMANS; MAGNESIUM; MICROARRAY ANALYSIS; MICRORNAS; MOLECULAR STRUCTURE; PEPTIDE LIBRARY; PEPTOIDS; RIBONUCLEASE III; RNA PROCESSING, POST-TRANSCRIPTIONAL; SMALL MOLECULE LIBRARIES;

EID: 84896502464     PISSN: 13558382     EISSN: 14699001     Source Type: Journal    
DOI: 10.1261/rna.042911.113     Document Type: Article

References (52)

1. Alvarez SG, Alvarez MT. 1997. A practical procedure for the synthesis of alkyl azides at ambient temperature in dimethyl sulfoxide in high purity and yield. Synthesis 4: 413-414.
2. Asangani IA, Rasheed SAK, Nikolova DA, Leupold JH, Colburn NH, Post S, Allgayer H. 2008. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136.
3. Avitabile C, Saviano M, D'Andrea L, Bianchi N, Fabbri E, Brognara E, Gambari R, Romanelli A. 2012. Targeting pre-miRNA by peptide nucleic acids: A new strategy to interfere in the miRNA maturation. Artif DNA PNA XNA 3: 88-96.
4. Bartel DP. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
5. Beisel CL, Chen YY, Culler SJ, Hoff KG, Smolke CD. 2011. Design of small molecule-responsive microRNAs based on structural requirements for Drosha processing. Nucleic Acids Res 39: 2981-2994.
6. Bose D, Jayaraj G, Suryawanshi H, Agarwala P, Pore SK, Banerjee R, Maiti S. 2012. The tuberculosis drug streptomycin as a potential cancer therapeutic: Inhibition of miR-21 function by directly targeting its precursor. Angew Chem Int Ed Engl 51: 1019-1023.
7. Bradrick TD, Marino JP. 2004. Ligand-induced changes in 2-aminopurine fluorecence as a probe for small molecule binding to HIV-1 TAR RNA. RNA 10: 1459-1468.
8. Carlson CB, Beal PA. 2002. Point of attachment and sequence of immobilized peptoid-acridine conjugates control affinity for nucleic acids. J Am Chem Soc 124: 8510-8511.
9. Chan JA, Krichevsky AM, Kosik KS. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029-6033.
10. Chekulaeva M, Filipowicz W. 2009. Mechanisms of miRNA-mediated post-transcriptional regulation in animal cells. Curr Opin Cell Biol 21: 452-460.
11. Chirayil S, Luebke KJ. 2012. Cyclization of peptoids by formation of boronate esters. Tetrahedron Lett 53: 726-729.
12. Chirayil S, Chirayil R, Luebke KJ. 2009. Discovering ligands for a microRNA precursor with peptoid microarrays. Nucleic Acids Res 37: 5486-5497.
13. Davis BN, Hilyard AC, Lagna G, Hata A. 2008. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 454: 56-61.
14. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. 2010. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 39: 373-384.
15. Disney MD, Seeberger PH. 2004. Aminoglycoside microarrays to explore interactions of antibiotics with RNAs and proteins. Chemistry 10: 3308-3314.
16. Garzon R, Calin G, Croce C. 2009. MicroRNAs in cancer. Annu Rev Med 60: 167-179.
17. Gregory RI, Yan KP, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R. 2004. The Microprocessor complex mediates the genesis of microRNAs. Nature 432: 235-240.
18. Han J, Lee Y, Yeom KH, Kim YK, Jin H, Kim VN. 2004. The Drosha- DGCR8 complex in primary microRNA processing. Genes Dev 18: 3016-3027.
19. Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee JK, Sohn SY, Cho Y, Zhang BT, Kim VN. 2006. Molecular basis for the recognition of primarymicroRNAs by the Drosha-DGCR8complex. Cell 125: 887-901.
20. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E, Olson EN. 2010. Modulation of K-Ras-dependent lung tumorigenesis by microRNA-21. Cancer Cell 18: 282-293.
21. Hutvagner G, McLachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. 2001. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293: 834-838.
22. Krishnamurthy M, Simon K, Orendt AM, Beal PA. 2007. Macrocyclic helix-threading peptides for targeting RNA. Angew Chem Int Ed Engl 46: 7044-7047.
23. Kwon YU, Kodadek T. 2007. Quantitative evaluation of the relative cell permeability of peptoids and peptides. J Am Chem Soc 129: 1508-1509.
24. Lam KS, Salmon SE, Hersh EM, Hruby VJ, Kazmierski WM, Knapp RJ. 1991. A new type of synthetic peptide library for identifying ligandbinding activity. Nature 354: 82-84.
25. Landthaler M, Yalcin A, Tuschl T. 2004. The human DiGeorge syndrome critical region gene 8 and its D. melanogaster homolog are required for miRNA biogenesis. Curr Biol 14: 2162-2167.
26. Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J, Lee J, Provost P, Radmark O, Kim S, et al. 2003. The nuclear RNAse III Drosha initiates microRNA processing. Nature 425: 415-419.
27. Lund E, Guttinger S, Calado A, Dahlberg JE, Kutay U. 2004. Nuclear export of microRNA precursors. Science 303: 95-98.
28. Lunse CE, Michlewski G, Hopp CS, Rentmeister A, Caceres JF, Famulok M, Mayer G. 2010. An aptamer targeting the apical-loop domain modulates pri-miRNA processing. Angew Chem Int Ed Engl 49: 4674-4677.
29. Maiti M, Nauwelaerts K, Herdewijn P. 2012. Pre-microRNA binding aminoglycosides and antitumor drugs as inhibitors of Dicer catalyzed microRNA processing. Bioorg Med Chem Lett 22: 1709-1711.
30. Michlewski G, Guil S, Semple CA, Caceres JF. 2008. Posttranscriptional regulation of miRNAs harboring conserved terminal loops. Mol Cell 32: 383-393.
31. Moriyama T, Ohuchida K, Mizumoto K, Yu J, Sato N, Nabae T, Takahata S, Toma H, Nagai E, Tanaka M. 2009. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther 8: 1067-1074.
32. Murata A, Fukuzumi T, Umemoto S, Nakatani K. 2013. Xanthone derivatives as potential inhibitors of miRNA processing by human Dicer: Targeting secondary structures of pre-miRNA by small molecules. Bioorg Med Chem Lett 23: 252-255.
33. Neubacher S, Dojahn CM, Arenz C. 2011. A rapid assay for miRNA maturation by using unmodified pre-miRNA. Chembiochem 12: 2302-2305.
34. Newman MA, Thomson JM, Hammond SM. 2008. Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing. RNA 14: 1539-1549.
35. Nnanabu E, Burgess K. 2006. Cyclic semipeptoids: Peptoid-organic hybrid macrocycles. Org Lett 8: 1259-1262.
36. Obernosterer G, Leuschner PJ, Alenius M, Martinez J. 2006. Posttranscriptional regulation of microRNA expression. RNA 12: 1161-1167.
37. Piskounova E, Viswanathan SR, Jana M, LaPierre RJ, Daley GQ, Sliz P, Gregory RI. 2008. Determinants of microRNA processing inhibition by the developmentally regulated RNA-binding protein Lin28. J Biol Chem 283: 21310-21314.
38. Soukup GA, Breaker RR. 1999. Relationship between internucleotide linkage geometry and the stability of RNA. RNA 5: 1308-1325.
39. Thomas JR, Hergenrother PJ. 2008. Targeting RNA with small molecules. Chem Rev 108: 1171-1224.
40. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM. 2006. Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes Dev 20: 2202-2207.
41. Trabucchi M, Briata P, Garcia-Mayoral M, Haase AD, Filipowicz W, Ramos A, Gherzi R, Rosenfeld MG. 2009. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 459: 1010-1014.
42. Tran T, Disney MD. 2012. Identifying the preferred RNA motifs and chemotypes that interact by probing millions of combinations. Nat Commun 3: 1125.
43. Uno T, Beausoleil E, Goldsmith RA, Levine BH, Zuckermann RN. 1999. New submonomers for poly N-substituted glycines (peptoids). Tetrahedron Lett 40: 1475-1478.
44. Viswanathan SR, Daley GQ, Gregory RI. 2008. Selective blockade of microRNA processing by Lin28. Science 320: 97-100.
45. Volinia S, Calin G, Liu C-G, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Ferracin M, Prueitt RL, et al. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci 103: 2257-2261.
46. Zeng Y, Cullen BR. 2005a. Efficient processing of primary microRNA hairpins by Drosha requires flanking nonstructured RNA sequences. J Biol Chem 280: 27595-27603.
47. Zeng Y, Cullen BR. 2005b. Single-stranded extensions on primary microRNA transcripts are required for Drosha cleavage. J Biol Chem 280: 27595-27603.
48. Zeng Y, Yi R, Cullen BR. 2005. Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme DROSHA. EMBO J 24: 138-148.
49. Zhang X, Zeng Y. 2010. The terminal loop region controls microRNA processing by Drosha and Dicer. Nucleic Acids Res 38: 7689-7697.
50. Zhu S, Si M-L, Mo Y-Y. 2007. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336.
51. Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. 2008. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 18: 350-359.
52. Zuker M. 2003. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31: 3406-3415.